CA Stock MarketDetailed Quotes
PAS Pascal Biosciences Inc
- 0.000
- 0.0000.00%
15min DelayTrading Sep 24 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00052wk High0.00%Turnover Ratio65.59MShares0.00052wk Low-0.01EPS TTM0Float Cap0.000Historical High0.00P/E (Static)65.59MShs Float0.000Historical Low-0.01EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Pascal Biosciences Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | (Q3)Aug 31, 2022 | (Q2)May 31, 2022 | (Q1)Feb 28, 2022 | (FY)Nov 30, 2021 | (Q4)Nov 30, 2021 | (Q3)Aug 31, 2021 | (Q2)May 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -69.71%-80.75K | 75.98%-147.68K | 60.89%-25.84K | 71.81%-50.12K | 87.50%-24.14K | 73.25%-47.58K | 28.73%-614.93K | 39.50%-66.08K | 19.46%-177.79K | -5.81%-193.16K |
| Net income from continuing operations | 2.09%-132.63K | 55.89%-480.28K | 49.91%-201.45K | 60.74%-94.73K | 83.00%-48.63K | 15.00%-135.46K | 12.04%-1.09M | -21,214.04%-402.2K | 24.83%-241.28K | 30.84%-286.09K |
| Operating gains losses | ---7.24K | ---104.8K | ---18.25K | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | --0 | -49.19%8.29K | -29.92%2.27K | -87.03%563 | -61.39%2.73K | 63.35%2.73K | 30.83%16.33K | 199.35%3.25K | -52.78%4.34K | 543.13%7.07K |
| Asset impairment expenditure | ---- | 155.26%129.48K | ---- | ---- | ---- | ---- | --50.72K | ---- | ---- | ---- |
| Remuneration paid in stock | -88.56%1.77K | -76.27%47.47K | -83.60%4.17K | -92.38%7.82K | -71.80%19.97K | 1,245.01%15.51K | 1,188.75%200.03K | 1,642.88%25.45K | 5,503.60%102.6K | 1,687.63%70.83K |
| Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | --46K | ---- | ---- | ---- |
| Change In working capital | -17.65%57.36K | 56.69%252.15K | -72.51%57.93K | 183.36%36.23K | 487.74%88.34K | 426.30%69.65K | -59.08%160.93K | 517.53%210.7K | -157.23%-43.46K | -93.35%15.03K |
| -Change in receivables | -460.91%-3.83K | 104.89%5.32K | 100.41%559 | -154.84%-5.31K | -85.18%10.75K | 98.79%-683 | -56.74%-108.93K | -78.49%-134.83K | 47.49%9.68K | 657.35%72.56K |
| -Change in prepaid assets | 92.85%-988 | -100.72%-53 | 50.20%6.29K | 5.58%6.34K | 118.51%1.14K | -509.15%-13.82K | -56.26%7.41K | -51.43%4.19K | -46.76%6.01K | -751.24%-6.16K |
| -Change in payables and accrued expense | -26.11%62.18K | -5.93%246.88K | -85.03%51.09K | 159.50%35.19K | 248.83%76.45K | 166.18%84.15K | -41.13%262.45K | 1,973.80%341.35K | -201.81%-59.14K | -121.76%-51.37K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -69.71%-80.75K | 75.98%-147.68K | 60.89%-25.84K | 71.81%-50.12K | 87.50%-24.14K | 73.25%-47.58K | 28.73%-614.93K | 39.50%-66.08K | 19.46%-177.79K | -5.81%-193.16K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 7.24K | 8.98K | 8.34K | 0 | 0 | 0 | ||||
| Net PPE purchase and sale | --7.24K | --8.98K | --8.34K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --7.24K | --8.98K | --8.34K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 25.90%75.54K | -75.19%154.84K | -64.72%8.96K | -26.41%40.96K | 195.22%44.92K | -88.63%60K | 32.48%624.08K | 3,399.48%25.41K | -57.32%55.66K | -95.54%15.21K |
| Net issuance payments of debt | -5.57%75.54K | 283.16%174.84K | -64.72%8.96K | 717.50%40.96K | 195.22%44.92K | --80K | -64.81%45.63K | --25.41K | --5.01K | --15.21K |
| Net common stock issuance | ---- | --0 | --0 | --0 | ---- | ---- | 82.91%624.5K | --0 | ---125.5K | -44.35%190K |
| Net other financing activities | ---- | 56.57%-20K | --0 | --0 | --0 | 37.89%-20K | ---46.05K | --0 | --176.15K | ---190K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 25.90%75.54K | -75.19%154.84K | -64.72%8.96K | -26.41%40.96K | 195.22%44.92K | -88.63%60K | 32.48%624.08K | 3,399.48%25.41K | -57.32%55.66K | -95.54%15.21K |
| Net cash flow | ||||||||||
| Beginning cash position | 207.87%8.37K | 54.11%-7.76K | -66.07%16.91K | -83.59%25.44K | -98.67%4.66K | ---7.76K | -104.51%-16.91K | -37.43%49.82K | -15.47%155.05K | 3,053.45%349.91K |
| Current changes in cash | -83.57%2.04K | 76.27%16.13K | 79.01%-8.54K | 93.01%-8.53K | 111.68%20.78K | -96.45%12.42K | 102.34%9.15K | 63.02%-40.67K | -35.22%-122.13K | -212.02%-177.95K |
| End cash Position | 123.22%10.41K | 207.87%8.37K | 207.87%8.37K | -66.07%16.91K | -83.59%25.44K | -98.67%4.66K | 54.11%-7.76K | 54.11%-7.76K | -37.43%49.82K | -15.47%155.05K |
| Free cash from | -69.71%-80.75K | 75.98%-147.68K | 60.89%-25.84K | 71.81%-50.12K | 87.50%-24.14K | 73.25%-47.58K | 28.73%-614.93K | 39.50%-66.08K | 19.46%-177.79K | -5.81%-193.16K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data